Phase III or marketed compounds

The marketing and scientific evaluation of Phase III or further developed licensing or acquisition opportunities is led by Ferring’s ‘Global Marketing Department’. This group consults with the appropriate Ferring divisions and affiliates.

With regards to search and transactions management, please contact the 'Global Business Director' according to the therapy area he is responsible for:

Head of Global Business Development
Andreas Segerros
Vice President, Global Business Development
Phone +41 58 301 01 50
aseg@ferring.com
 
Urology, Uro-Oncology and Drug Delivery
Jim Garrison
Vice President, Global Business Development
Phone +1 973 7961689
jgar@ferring.com
 
Infertility and OB/Gyn
Jan Honoré
Senior Director, Global Business Development
Phone +41 58 301 03 68
jah@ferring.com
 
Gastro, Endocrinology and Orthopaedic
David Benathan
Director, Global Business Development
Phone +41 58 301 02 05
dbe@ferring.com

Assistant
Marie Favre
Phone +41 58 301 00 91
mfv@ferring.com